J2326 Injection, nusinersen, 0.1mg
Also known as: nusinersen, Spinraza
Injection of nusinersen, 0.1 milligram. An antisense oligonucleotide for spinal muscular atrophy.
In Plain Language
muscle weakness disease treatment; genetic disorder medication
Clinical Context
Used for spinal muscular atrophy through intrathecal administration. Nusinersen increases production of survival motor neuron protein.
RVU Information
CPT J2326 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2326?
CPT J2326 (Injection, nusinersen, 0.1mg) is a J Codes (Drugs) code. Injection of nusinersen, 0.1 milligram. An antisense oligonucleotide for spinal muscular atrophy.
How is J2326 administered?
CPT J2326 is administered by a healthcare provider, typically via injection or infusion. Used for spinal muscular atrophy through intrathecal administration. Nusinersen increases production of survival motor neuron protein. It is used by Neurology, Genetics, Pediatrics.
When is CPT J2326 used?
Used for spinal muscular atrophy through intrathecal administration. Nusinersen increases production of survival motor neuron protein.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.